Previous studies indicate that miR-150 mitigates adverse remodeling and fibrosis following myocardial infarction by targeting pro-fibrotic genes such as Hoxa4 and apoptosis-related genes like Gdap1l1, thereby improving cardiac function [43]. The gene discussed is HOXA4; the disease is myocardial infarction.